Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06242925 · ClinicalTrials.gov registry record · NA
Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)
A NA study of Open Abdomen, sponsored by Tufts Medical Center.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT06242925: Active NA study of Open Abdomen, sponsored by Tufts Medical Center.
NCT06242925 is a NA study of Open Abdomen that is active but no longer recruiting, run by Tufts Medical Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06242925, a NA study of Open Abdomen, is active but no longer recruiting, sponsored by Tufts Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this multicenter, prospective Cohort Interventional study is to perform a pilot study of the AbCLO (Abdominal Wall Closure) device in patients with Open Abdomen. The main question it aims to answer is: • Does the Abdominal Wall Closure Device (AbCLO) increase the likelihood of primary facial closure in cases of open abdomen when compared to historical controls? Participants will be cases of open abdomen who underwent emergency surgery for Trauma or Acute Care Surgery, will have the AbCLO device. These will be compared to historical controls managed at the same center.
Primary Outcome
Proportion of patients achieved primary facial closure within 14 days. (This is defined as approximation of the fascia on either side of the midline to perform suture closure without using any mesh or additional procedures.
Conditions Studied
Interventions
- DEVICE AbCLO (Abdominal Wall Closure) Device
Study Locations (2)
California
- Los Angeles County + University of Sothern California Medical Center - Los Angeles
Massachusetts
- Tufts Medical center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06242925 still lists
NCT06242925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Open Abdomen appearing as the primary indexed condition, and to 1 intervention - of which AbCLO (Abdominal Wall Closure) Device is the first listed.
NCT06242925 reports a single indexed study location in California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06242925 about?
NCT06242925 is a clinical study titled "Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)". The goal of this multicenter, prospective Cohort Interventional study is to perform a pilot study of the AbCLO (Abdominal Wall Closure) device in patients with Open Abdomen. The main question it aims to answer is: • Does the Abdominal Wall Closure Device (AbCLO) increase the likelihood of primary f...
What is the current status of trial NCT06242925?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06242925 study?
This clinical trial studies the following conditions: Open Abdomen.
What interventions are being tested in trial NCT06242925?
The interventions under investigation include: AbCLO (Abdominal Wall Closure) Device (DEVICE).
Who is sponsoring clinical trial NCT06242925?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06242925 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06242925's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI